Track topics on Twitter Track topics that are important to you
Blade Therapeutics, a private biopharmaceutical company advancing novel anti-fibrotic therapies to meet important patient needs, announced the appointment of Maria E. Fuentes, Ph.D., as Executive Vice President, Research. In this newly established position, Dr. Fuentes will lead Blade’s anti-fibrotic programs in preclinical testing. Blade’s flagship program, focused on a small molecule cysteine protease inhibitor, is expected […]
The post Blade Therapeutics appoints Dr. Maria E. Fuentes EVP, Research appeared first on CenterWatch News Online.
Original Article: Blade Therapeutics appoints Dr. Maria E. Fuentes EVP, ResearchNEXT ARTICLE